DNA adduct burden and tobacco carcinogenesis

Oncogene

Volumn 21, Issue 48 REV. ISS. 6, 2002, Pages 7376-7391

  Wiencke, John K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA adducts; Molecular epidemiology; Risk assessment; Tobacco

Indexed keywords

CARCINOGEN; TOBACCO SMOKE;

AIR QUALITY; ARTICLE; CANCER RISK; CARCINOGENESIS; DNA ADDUCT; DNA REPAIR; DOSE RESPONSE; GENETIC POLYMORPHISM; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; PRIORITY JOURNAL; SMOKING; TOBACCO;

CELL TRANSFORMATION, NEOPLASTIC; DNA ADDUCTS; DNA REPAIR; HUMANS; LUNG NEOPLASMS; RISK FACTORS; TOBACCO;

NICOTIANA TABACUM;

EID: 0037152633     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205799     Document Type: Article

References (196)

1. Alexandrov K, Rojas M, Geneste O, Castegnaro M, Camus AM, Petruzzelli S, Giuntini C and Bartsch H. (1992). Cancer Res., 52, 6248-6253.
2. Andreassen A, Kure EH, Nielsen PS, Autrup H and Haugen A. (1996). Mutat. Res., 368, 275-282.
3. Aoki Y, Sato H, Nishimura N, Takahashi S, Itoh K and Yamamoto M. (2001). Toxicol. Appl. Pharmacol., 173, 154-160.
4. Arnould JP, Kubiak R, Belowski J, Belegaud J and Szczeklik J. (2000). Pathol. Bio. (Paris), 48, 548-553.
5. Arnould JP, Pfohl-Leszkowicz A, Bach V, Libert JP and Belegaud J. (1999). Hum. Exp. Toxicol., 18, 314-321.
6. Banaszewski J, Szmeja Z, Szyfter W, Szyfter K, Baranczewski P and Moller L. (2000). Eur. Arch. Otorhinolaryngol., 257, 149-153.
7. Bartsch H and Nair J. (2001). Adv. Exp. Med. Biol., 500, 675-686.
8. Bartsch H, Rojas M, Alexandrov K and Risch A. (1998). Recent Results Cancer Res., 154, 86-96.
9. Beserati Nia A, Van Straaten HW, Godschalk RW, Van Zandwijk N, Balm AJ, Kleinjans JC and Van Schooten FJ. (2000). Environ. Mol. Mutagen, 36, 127-133.
10. Binkova B, Topinka J, Mrackova G, Gajdosova D, Vidova P, Stavkova Z, Peterka V, Pilcik T, Rimar V, Dobias L, Farmer PB and Sram RJ. (1998). Muta. Res., 416, 67-84.
11. Blair IA. (2001). Exp. Gerontol., 36, 1473-1481.
12. Bodell WJ, Devanesan PD, Rogan EG and Cavalieri EL. (1989). Chem. Res. Toxicol., 2, 312-315.
13. Bonassi S, Neri M and Puntoni R. (2001). Murat. Res., 480-481, 349-358.
14. Bucci F, Galati R, Zito R, Falasca G, Federico A and Verdina A. (1998). Anticancer Res., 18, 2669-2674.
15. Burcham PC. (1998). Mutagenesis, 13, 287-305.
16. Butkiewicz D, Grzybowska E, Phillips DH, Hemminki K and Chorazy M. (2000). Environ. Mol. Mutagen., 35, 99-105.
17. Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M and Harris CC. (2001). Carcinogenesis, 22, 593-597.
18. Carmichael PL. (1998). Arch. Toxicol., 20 (Suppl): 199-205.
19. Casale GP, Singhal M, Bhattacharya S, RamaNathan R, Roberts KP, Barbacci DC, Zhao J, Jankowiak R, Gross ML, Cavalieri EL, Small GJ, Rennard SI, Mumford JL and Shen M. (2001). Chem. Res. Toxicol., 14, 192-201.
20. Chakravarti D, Mailander PC, Li KM, Higginbotham S, Zhang HL, Gross ML, Meza JL, Cavalieri EL and Rogan EG. (2001). Oncogene, 20, 7945-7953.
21. Chen HJ, Zhang L, Cox J, Cunningham JA and Chung FL. (1998). Chem. Res. Toxicol., 11, 1474-1480.
22. Chen L, Devanesan PD, Higginbotham S, Ariese F, Jankowiak R, Small GJ, Rogan EG and Cavalieri EL. (1996). Chem. Res. Toxicol., 9, 897-903.
23. Cheng L, Spitz MR, Hong WK and Wei Q. (2000a). Carcinogenesis, 21, 1527-1530.
24. Cheng YW, Chen CY, Lin P, Huang KH, Lin TS, Wu MH and Lee H. (2000b). Eur. J. Cancer, 36, 1381-1388.
25. Cheng YW, Hsieh LL, Lin PP, Chen CP, Chen CY, Lin TS, Su JM and Lee H. (2001). Environ. Mol. Mutagen., 37, 304-310.
26. Coles B, Yang M, Lang NP and Kadlubar FF. (2000a). Cancer Lett., 156, 167-175.
27. Coles BF, Anderson KE, Doerge DR, Churchwell MI, Lang NP and Kadlubar FF. (2000b). Cancer Res., 60, 573-579.
28. Cuzick J. (1995). J. Natl. Cancer Inst., 87, 861-862.
29. David-Beabes GL and London SJ. (2001). Lung Cancer, 34, 333-339.
30. Devanesan PD, Higginbotham S, Ariese F, Jankowiak R, Suh M, Small GJ, Cavalieri EL and Rogan EG. (1996). Chem. Res. Toxicol., 9, 1113-1116.
31. Divine KK, Gilliland FD, Crowell RE, Stidley CA, Bocklage TJ, Cook DL and Belinsky SA. (2001). Mutat. Res., 461, 273-278.
32. Duell EJ, Holly EA, Bracci PM, Liu M, Wiencke JK and Kelsey KT. (2002). J. Natl. Cancer Inst., 94, 297-306.
33. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, Mark EJ, Wain JC, Christiani DC and Kelsey KT. (2000). Carcinogenesis, 21, 965-971.
34. Endo C, Sato M, Fujimura S, Sakurada A, Aikawa H, Takahashi S, Usuda K, Saito Y and Sagawa M. (2000). Surg. Today, 30, 695-699.
35. Fennell TR, MacNeela JP, Morris RW, Watson M, Thompson CL and Bell DA. (2000). Cancer Epidemiol. Biomarkers Prev., 9, 705-712.
36. Fields WR, Morrow CS, Doss AJ, Sundberg K, Jernstrom B and Townsend AJ. (1998). Mol. Pharmacol., 54, 298-304.
37. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, Ritchey DM and Miller YE. (1997). J. Clin. Invest., 100, 2133-2137.
38. Garner RC. (1998). Mutat. Res., 402, 67-75.
39. Godschalk RW, Dallinga JW Wikman H, Risch A, Kleinjans JC, Bartsch H and Van Schooten FJ. (2001). Pharmacogenetics, 11, 389-398.
40. Godschalk RW, Maas LM, Van Zandwijk N, van't Veer LJ, Breedijk A, Borm PJ, Verhaert J, Kleinjans JC and van Schooten FJ. (1998). Carcinogenesis, 19, 819-825.
41. Goldman R, Enewold L, Pellizzari E, Beach JB, Bowman ED, Krishnan SS and Shields PG. (2001). Cancer Res., 61, 6367-6371.
42. Grant DJ and Bell DA. (2000). Mol. Carcinog., 29, 198-204.
43. Grinberg-Funes RA, Singh VN, Perera FP, Bell DA, Young TL, Dickey C, Wang LW and Santella RM. (1994). Carcinogenesis, 15, 2449-2454.
44. Grzybowska E, Butkiewicz D, Motykiewicz G and Chorazy M. (2000). Mutat. Res., 469, 271-277.
45. Grzybowska E, Hemminki K, Szeliga J and Chorazy M. (1993). Carcinogenesis, 14, 2523-2526.
46. Gupta RC, Arif JM and Gairola CG. (1999). Mutat. Res., 424, 195-205.
47. Hardie LJ, Briggs JA, Davidson LA, Allan JM, King RF, Williams GI and Wild CP. (2000). Carcinogenesis, 21, 167-172.
48. Harries LW, Stubbins MJ, Forman D, Howard GC and Wolf CR. (1997). Carcinogenesis, 18, 641-644.
49. Hecht SS, McIntee EJ and Wang M. (2001). Toxicology, 166, 31-36.
50. Hegmann KT, Fraser AM, Keaney RP, Moser SE, Nilasena DS, Sedlars M, Higham-Gren L and Lyon JL. (1993). Epidemiology, 4, 444-448.
51. Helleberg H, Xu H, Ehrenberg L, Hemminki K, Rannug U and Tornqvist M. (2001). Mutagenesis, 16, 333-337.
52. Hemminki K, Koskinen M, Rajaniemi H and Zhao C. (2000). Regul. Toxicol. Pharmacol., 32, 264-275.
53. Hemminki K, Koskinen M and Zhao C. (2001). Int. J. Cancer, 92, 923-926.
54. Hirao T, Nelson HH, Ashok TD, Wain JC, Mark EJ, Christiani DC, Wiencke JK and Kelsey KT. (2001). Cancer Res., 61, 612-615.
55. Hoque A, Albanes D, Lippman SM, Spitz MR, Taylor PR, Klein EA, Thompson IM, Goodman P, Stanford JL, Crowley JJ, Coltman CA and Santella RM. (2001). Cancer Causes Control, 12, 627-633.
56. Hou SM, Falt S, Yang K, Nyberg F, Pershagen G, Hemminki K and Lambert B. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 133-140.
57. Hu X, Herzog C, Zimniak P and Singh SV. (1999). Cancer Res., 59, 2358-2362.
58. Izzotti A, Bagnasco M, D'Agostini F, Cartiglia C, Lubet RA, Kelloff GJ and De Flora S. (1999). Carcinogenesis, 20, 1499-1505.
59. Jacobson JS, Begg MD, Wang LW, Wang Q, Agarwal M, Norkus E, Singh VN, Young TL, Yang D and Santella RM. (2000). Cancer Epidemiol. Biomarkers Prev., 9, 1303-1311.
60. Jaiswal AK, Bell DW, Radjendirane V and Testa JR. (1999). Pharmacogenetics, 9, 413-418.
61. Josyula S, Schut HA, Diwan BA, Anver MR and Anderson LM. (2000). Int. J. Oncol., 17, 811-818.
62. Kadlubar FF, Anderson KE, Haussermann S, Lang NP, Barone GW, Thompson PA, MacLeod SL, Chou MW, Mikhailova M, Plastaras J, Marnett LJ, Nair J, Velic I and Bartsch H. (1998). Mutat. Res., 405, 125-133.
63. Kantarci OH, Lesnick TG, Yang P, Meyer RL, Hebrink DD, McMurray CT and Weinshenker BG. (2002). Mayo Clin. Proc., 77, 17-22.
64. Kato S, Bowman ED, Harrington AM, Blomeke B and Shields PG. (1995). J. Natl. Cancer Inst., 87, 902-907.
65. Kihara M and Noda K. (1999). Cancer Lett., 137, 53-60.
66. Kriek E, Rojas M, Alexandrov K and Bartsch H. (1998). Mutat. Res., 400, 215-231.
67. Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R and Haugen A. (1996). Carcinogenesis, 17, 2201-2215.
68. Kyrtopoulos SA, Georgiadis P, Autrup H, Demopoulos N, Farmer P, Haugen A, Katsouyanni K, Lambert B, Ovrebo S, Sram R, Stefanou G and Topinka J. (2001). Mutat. Res., 496, 207-228.
69. Le Marchand L, Seifried A, Lum A and Wilkens LR. (2000). Cancer Epidemiol. Biomarkers Prev., 9, 181-184.
70. Leuratti C, Singh R, Lagneau C, Farmer PB, Plastaras JP, Marnet LJ and Shuker DE. (1998). Carcinogenesis, 19, 1919-1924.
71. Li D, Firozi PF, Chang P, Wang LE, Xiong P, Sturgis EM, Eicher SA, Spitz MR, Hong WK and Wei Q. (2001a). Int. J. Cancer, 93, 436-440.
72. Li D, Firozi PF, Wang LE, Bosken CH, Spitz MR, Hong WK and Wei Q. (2001b). Cancer Res., 61, 1445-1450.
73. Li D, Firozi PF, Zhang W, Shen J, DiGiovanni J, Lau S, Evans D, Friess H, Hassan M and Abbruzzese JL. (2002). Mutat. Res., 513, 37-48.
74. Lodovici M, Akpan V, Giovannini L, Migliani F and Dolara P. (1998). Chem. Biol. Interact., 116, 199-212.
75. London SJ, Lehman TA and Taylor JA. (1997). Cancer Res., 57, 5001-5003.
76. Long 2nd DJ and Jaiswal AK. (2000). Chem. Biol. Interact., 129, 99-112.
77. Marcus PM, Vineis P and Rothman N. (2000). Pharmacogenetics, 10, 115-122.
78. Martone T, Airoldi L, Magagnotti C, Coda R, Randone D, Malaveille C, Avanzi G, Merletti F, Hautefeuille A and Vineis P. (1998). Int. J. Cancer, 75, 512-516.
79. Marzilli LA, Koertje C and Vouros P. (2001). Methods Mol. Biol., 162, 395-406.
80. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, Piazza A and Vineis P. (2001a). Int. J. Cancer, 92, 562-567.
81. Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Celentano E, Krogh V, Munnia A, Tumino R, Polidoro S, Piazza A and Vineis P. (2001b). Carcinogenesis, 22, 1437-1445.
82. Melendez-Colon VJ, Luch A, Seidel A and Baird WM. (1999). Carcinogenesis, 20, 1885-1891.
83. Melendez-Colon VJ, Smith CA, Seidel A, Luch A, Platt KL and Baird WM. (1997). Proc. Natl. Acad. Sci. USA, 94, 13542-13547.
84. Melikian AA, Sun P, Prokopczyk B, El-Bayoumy K, Hoffman D, Wang X and Waggoner S. (1999a). Cancer Lett., 146, 127-134.
85. Melikian AA, Wang X, Waggoner S, Hoffmann D and El-Bayoumy K. (1999b). Oncol. Rep., 6, 1371-1376.
86. Misra RR, Tangrea JA, Virtamo J, Ratnasinghe D, Andersen MR, Barrett M, Taylor PR and Albanes D. (2001). Cancer Lett., 164, 161-167.
87. Mitsudomi T, Oyama T, Nishida K, Ogami A, Osaki T, Sugio K, Yasumoto K, Sugimachi K and Gazdar AF. (1996). Clin. Cancer Res., 2, 1185-1189.
88. Moller L, Grzybowska E, Zeisig M, Cimander B, Hemminki K and Chorazy M. (1996). Carcinogenesis, 17, 61-66.
89. Moller P and Wallin H. (1998). Mutat. Res., 410, 271-290.
90. Mollerup S, Ryberg D, Hewer A, Phillips DH and Haugen A. (1999). Cancer Res., 59, 3317-3320.
91. Mooney LA, Bell DA, Santella RM, Van Bennekum AM, Ottman R, Paik M, Blaner WS, Lucier GW, Covey L, Young TL, Cooper TB, Glassman AH and Perera FP. (1997). Carcinogenesis, 18, 503-509.
92. Mooney LA, Santella RM, Covey L, Jeffrey AM, Bigbee W, Randall MC, Cooper TB, Ottman R, Tsai WY and Wazneh L et al. (1995). Cancer Epidemiol. Biomarkers Prev., 4, 627-634.
93. Motykiewicz G, Michalska J, Pendzich J, Malusecka E, Strozyk M, Kalinowska E, Butkiewicz D, Mielzynska D, Midro A, Santella RM and Chorazy M. (1998). Toxicol. Lett., 96-97, 195-202.
94. Nair J, Gal A, Tamir S, Tannenbaum SR, Wogan GN and Bartsch H. (1998). Carcinogenesis, 19, 2081-2084.
95. Nath RG, Ocando JE, Guttenplan JB and Chung FL. (1998). Cancer Res., 58, 581-584.
96. Nelson HH, Kelsey KT, Mott LA and Karagas MR. (2002). Cancer Res., 62, 152-155.
97. Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC and Kelsey KT. (1998). Cancer Res., 58, 1804-1807.
98. Ni J, Liu T, Kolbanovskiy A, Krzeminski J, Amin S and Geacintov NE. (1998). Anal. Biochem., 264, 222-229.
99. Nia AB, Maas LM, Brouwer EM, Kleinjans JC and Van Schooten FJ. (2000). Carcinogenesis, 21, 1335-1340.
100. Nowell S, Ambrosone CB, Ozawa S, MacLeod SL, Mrackova G, Williams S, Plaxco J, Kadlubar FF and Lang NP. (2000). Pharmacogenetics, 10, 789-797.
101. Olshan AF, Watson MA, Weissler MC and Bell DA. (2002). Cancer Lett., 178, 181-186.
102. Ozawa S, Schoket B, McDaniel LP, Tang YM, Ambrosone CB, Kostic S, Vincze I and Kadlubar FF. (1999). Carcinogenesis, 20, 991-995.
103. Palli D, Russo A, Masala G, Saieva C, Guarrera S, Carturan S, Munnia A, Matullo G and Peluso M. (2001). Int. J. Cancer, 94, 121-127.
104. Palli D, Vineis P, Russo A, Berrino F, Krogh V, Masala G, Munnia A, Panico S, Taioli E, Tumino R, Garte S and Peluso M. (2000). Int. J. Cancer, 87, 444-451.
105. Pan G, Hanaoka T, Yamano Y, Hara K, Ichiba M, Wang Y, Zhang J, Feng Y, Shujuan Z, Guan D, Gao G, Liu N and Takahashi K. (1998). Carcinogenesis, 19, 1963-1968.
106. Park IW, Wistuba II, Maitra A, Milchgrub S, Virmani AK, Minna J and Gazdar AF. (1999). J. Natl. Cancer Inst., 91, 1863-1868.
107. Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, Joo S, Kim CH, Park JH, Kam S, Kim IS and Jung TH. (2002). Cancer Epidemiol. Biomarkers Prev., 11, 23-27.
108. Pavanello S and Clonfero E. (2000). Mutat. Res., 463, 285-308.
109. Pavanello S, Favretto D, Brugnone F, Mastrangelo F, Dal Pra G and Clonfero E. (1999). Carcinogenesis, 20, 431-435.
110. Peluso M, Airoldi L, Armelle M, Martone T, Coda R, Malaveille C, Giacomelli G, Terrone C, Casetta G and Vineis P. (1998). Cancer Epidemiol. Biomarkers Prev., 7, 341-346.
111. Peluso M, Airoldi L, Magagnotti C, Fiorini L, Munnia A, Hautefeuille A, Malaveille C and Vineis P. (2000). Carcinogenesis, 21, 183-187.
112. Peluso M, Castegnaro M, Malaveille C, Friesen M, Garren L, Hautefeuille A, Vineis P, Kadlubar F and Bartsch H. (1991). Carcinogenesis, 12, 713-717.
113. Perera F, Brenner D, Jeffrey A, Mayer J, Tang D, Warburton D, Young TI, Wazneh L, Latriano L and Motykiewicz G et al. (1992). Environ. Health Perspect., 98, 133-137.
114. Perera F, Mayer J, Jaretzki A, Hearne S, Brenner D, Young TL, Fischman HK, Grimes M, Grantham S, Tang MX, Tsai WY and Santella RM. (1989). Cancer Res., 49, 4446-4451.
115. Petruska JM, Mosebrook DR, Jakab GJ and Trush MA. (1992). Carcinogenesis, 13, 1075-1081.
116. Petruzzelli S, Celi A, Pulera N, Baliva F, Viegi G, Carrozzi L, Ciacchini G, Bottai M, Di Pede F, Paoletti P and Giuntini C. (1998). Cancer Res., 58, 4122-4126.
117. Phillips DH and Castegnaro M. (1999). Mutagenesis, 14, 301-315.
118. Phillips DH, Farmer PB, Beland FA, Nath RG, Poirier MC, Reddy MV and Turteltaub KW. (2000). Environ. Mol. Mutagen., 35, 222-233.
119. Phillips DH, Hewer A, Martin CN, Garner RC and King MM. (1988). Nature, 336, 790-792.
120. Piipari R, Savela K, Nurminen T, Hukkanen J, Raunio H, Hakkola J, Mantyla T, Beaune P, Edwards RJ, Boobis AR and Anttila S. (2000). Int. J. Cancer, 86, 610-616.
121. Povey AC. (2000). Toxicol. Pathol., 28, 405-414.
122. Ratnasinghe D, Yao SX, Tangrea JA, Qiao YL, Andersen MR, Barrett MJ, Giffen CA, Erozan Y, Tockman MS and Taylor PR. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 119-123.
123. Reddy MV. (2000). Regul. Toxicol. Pharmacol., 32, 256-263.
124. Ren Q, Murphy SE, Zheng Z and Lazarus P. (2000). Drug Metab. Dispos., 28, 1352-1360.
125. Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, Dienemann H, Kayser K, Schulz V, Spiegelhalder B and Bartsch H. (2001). Pharmacogenetics, 11, 757-764.
126. Roberts KP, Lin CH, Singhal M, Casale GP, Small GJ and Jankowiak R. (2000). Electrophoresis, 21, 799-806.
127. Rojas M, Alexandrov K, Cascorbi I, Brockmoller J, Likhachev A, Pozharisski K, Bouvier G, Auburtin G, Mayer L, Kopp-Schneider A, Roots I and Bartsch H. (1998). Pharmacogenetics, 8, 109-118.
128. Rojas M, Cascorbi I, Alexandrov K, Kriek E, Auburtin G, Mayer L, Kopp-Schneider A, Roots I and Bartsch H. (2000). Carcinogenesis, 21, 35-41.
129. Rojas M, Godschalk R, Alexandrov K, Cascorbi I, Kriek E, Ostertag J, Van Schooten FJ and Bartsch H. (2001). Carcinogenesis, 22, 1015-1018.
130. Romano G, Sgambato A, Boninsegna A, Flamini G, Curigliano G, Yang Q, La Gioia V, Signorelli C, Ferro A, Capelli G, Santella RM and Cittadini A. (1999). Cancer Epidemiol. Biomarkers Prev., 8, 91-96.
131. Ryberg D, Hewer A, Phillips DH and Haugen A. (1994). Cancer Res., 54, 5801-5803.
132. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Vu P and Haugen A. (1997). Carcinogenesis, 18, 1285-1289.
133. Saha BK, Bishayee A, Kanjilal NB and Chatterjee M. (2001). Cell Mol. Life Sci., 58, 1141-1149.
134. Savela K and Hemminki K. (1991). Carcinogenesis, 12, 503-508.
135. Schabath MB, Spitz MR, Zhang X, Declos GL and Wu X. (2000). Carcinogenesis, 21, 1163-1166.
136. Schoket B, Kostic S and Vincze I. (1993). IARC Sci. Publ., 124, 315-319.
137. Schoket B, Papp G, Levay K, Mrackova G, Kadlubar FF and Vincze I. (2001). Mutat. Res., 482, 57-69.
138. Schoket B, Phillips DH, Kostic S and Vincze I. (1998). Carcinogenesis, 19, 841-846.
139. Seto H, Ohkubo T, Kanoh T, Koike M, Nakamura K and Kawahara Y. (1993). Arch. Environ. Contam. Toxicol., 24, 498-503.
140. Shields PG, Bowman ED, Harrington AM Doan VT and Weston A. (1993). Cancer Res., 53, 3486-3492.
141. Shinozaki R, Inoue S and Choi KS. (1998). Cytometry, 31, 300-306.
142. Shinozaki R, Inoue S, Choi KS and Tatsuno T. (1999). Arch. Environ. Health, 54, 79-85.
143. Soni M, Madurantakan M and Krishnaswamy K. (1998). Toxicology, 126, 155-162.
144. Stern MC, Umbach DM, van Gils CH, Lunn RM and Taylor JA. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 125-131.
145. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, Strom SS, Spitz MR and Wei Q. (1999). Carcinogenesis, 20, 2125-2129.
146. Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, Igarashi H, Morris BJ, Baba S, Ohno Y, Gao C, Li Z, Wang J, Takezaki T, Tajima K, Varga T, Sawaguchi T, Lum JK, Martinson JJ, Tsugane S, Iwamasa T, Shinmura K and Yokota J. (1999). Cancer Epidemiol. Biomarkers Prev., 8, 669-674.
147. Sundberg K, Dreij K, Seidel A and Jernstrom B. (2002). Chem. Res. Toxicol., 15, 170-179.
148. Szeliga J and Dipple A. (1998). Chem. Res. Toxicol., 11, 1-11.
149. Szyfter K, Banaszewski J, Jaolszynski P, Pabiszczak M, Szyfter W and Szmeja Z. (1999a). Acta Biochim. Pol., 46, 275-287.
150. Szyfter K, Szmeja Z, Szyfter W, Hemminki K, Banaszewski J, Jaskula-Sztul R and Louhelainen J. (1999b). Mutat. Res., 445, 259-274.
151. Talaska G, al-Juburi AZ and Kadlubar FF. (1991). Proc. Natl. Acad. Sci. USA, 88, 5350-5354.
152. Talaska G, Schamer M, Casetta G, Tizzani A and Vineis P. (1994). Cancer Lett., 84, 93-97.
153. Tan WG, Carnelley TJ, Murphy P, Wang H, Lee J, Barker S, Weinfeld M and Le XC. (2001). J. Chromatogr. A, 924, 377-386.
154. Tang D, Phillips DH, Stampfer M, Mooney LA, Hsu Y, Cho S, Tsai WY, Ma J, Cole KJ, She MN and Perera FP. (2001). Cancer Res., 61, 6708-6712.
155. Tang D, Santella RM, Blackwood AM, Young TL, Mayer J, Jaretzki A, Grantham S, Tsai WY and Perera FP. (1995). Cancer Epidemiol. Biomarkers Prev., 4, 341-346.
156. Tang DL, Rundle A, Warburton D, Santella RM, Tsai WY, Chiamprasert S, Hsu YZ and Perera FP. (1998). Carcinogenesis, 19, 1949-1953.
157. Thier R, Balkenhol H, Lewalter J, Selinski S, Dommermuth A and Bolt HM. (2001). Mutat. Res., 482, 41-46.
158. Thurston SW, Wand MP and Wiencke JK. (2000). Biometrics, 56, 139-144.
159. Timbrell JA. (1998). Toxicology, 129, 1-12.
160. Topinka J, Schwarz LR, Wiebel FJ, Cerna M and Wolff T. (2000). Mutat. Res., 469, 83-93.
161. Turteltaub KW and Dingley KH. (1998). Toxicol. Lett., 102-103, 435-439.
162. Uno S, Dalton TP, Shertzer HG, Genter MB, Warshawsky D, Talaska G and Nebert DW. (2001). Biochem. Biophys. Res. Commun., 289, 1049-1056.
163. Vainio H. (1998). Toxicol. Lett., 102-103, 581-519.
164. van Delft JH, Baan RA and Roza L. (1998a). Crit. Rev. Toxicol., 28, 477-510.
165. van Delft JHG, Steenwinkel MS, van Asten JG, de Vogel N, Bruijntjes-Rozier TC, Schouten T, Cramer P, Maas L, van Herwijnen MH, van Schooten F and Hopmans PM. (2001). Ann. Occup. Hyg., 45, 395-408.
166. van Delft JH, Steenwinkel MJ, van Asten JG, van Es J, Kraak A and Baan RA. (1998b). Ann. Occup. Hyg., 42, 105-114.
167. van Lieshout EM, Roelofs HM, Dekker S, Mulder CJ, Wobbes T, Jansen JB and Peters WH. (1999). Cancer Res., 59, 586-589.
168. Van Schooten FJ, Hirvonen A, Maas LM, De Mol BA, Kleinjans JC, Bell DA and Durrer JD. (1998). FASEB J., 12, 1409-1417.
169. Viezzer C, Norppa H, Clonfero E, Gabbani G, Mastrangelo G, Hirvonen A and Celotti L. (1999). Mutat. Res., 431, 259-269.
170. Vineis P, Kogevinas M, Simonato L, Brennan P and Boffetta P. (2000). Mutat. Res., 463, 103-110.
171. Vineis P and Martone T. (1996). Ann. Ist. Super Sanita, 32, 21-27.
172. Vineis P and Ronco G. (1992). Environ. Health Perspect., 98, 95-99.
173. Vulimiri SV, Wu X, Baer-Dubowska W, de Andrade M, Detry M, Spitz MR and DiGiovanni J. (2000). Mol. Carcinog., 27, 34-46.
174. Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, Chiao P and Li D. (1998a). Cancer Res., 58, 38-41.
175. Wang Y, Ichiba M, Iyadomi M, Zhang J and Tomokuni K. (1998b). Ind. Health, 36, 337-346.
176. Watson MA, Stewart RK, Smith GB, Massey TE and Bell DA. (1998). Carcinogenesis, 19, 275-280.
177. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK and Spitz MR. (2000). J. Natl. Cancer Inst., 92, 1764-1772.
178. Whyatt RM, Bell DA, Jedrychowski W, Santella RM, Garte SJ, Cosma G, Manchester DK, Young TL, Cooper TB, Ottman R and Perera FP. (1998). Carcionogenesis, 19, 1389-1392.
179. Whyatt RM, Perera FP, Jedrychowski W, Santella RM, Garte S and Bell DA. (2000). Cancer Epidemiol. Biomarkers Prev., 9, 207-221.
180. Whyatt RM, Jedruchowski W, Hemminki K, Santella RM, Tsai WY, Yang K and Perera FP. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 581-588.
181. Wiencke JK, Kelsey KT, Varkonyi A, Semey K, Wain JC, Mark E and Christiani DC. (1995). Cancer Res., 55, 4910-4914.
182. Wiencke JK, Nelson H, Wain J, Mark E, Christiani DC and Kelsey KT. (1998). Association of increased PAH-DNA adducts and p53 mutations in lung cancer. Proceedings of the 89th Annual Meeting of the American Association for Cancer Research 39: 1998, p 562.
183. Wiencke JK and Kelsey KT. (2002). Teen smoking, 'field cancerization' and a critical period hypothesis for lung cancer susceptibility Env. Health Perspect, June 2002.
184. Wiencke JK, Thurston SW, Kelsey KT, Varkonyi A, Wain JC, Mark EJ and Christiani DC. (1999). J. Natl. Cancer Inst., 91, 614-619.
185. Wikman H, Risch A, Klimek F, Schmezer P, Spiegelhalder B, Dienemann H, Kayser K, Schulz V, Drings P and Bartsch H. (2000). Int. J. Cancer, 88, 932-937.
186. Williams MD and Sandler AB. (2001). Cancer Treat. Res., 105, 31-52.
187. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon 3rd JW, Garner HR, McKay B, Latif F, Lerman MI, Lain S, Gazdar AF and Minna JD. (2000). Cancer Res., 60, 1949-1960.
188. Wistuba II, Bryant D, Behrens C, Milchgrub S, Virmani AK, Ashfaq R, Minna JD and Gazdar AF. (1999). Clin. Cancer Res., 5, 991-1000.
189. Xing JZ, Carnelley T, Lee J, Watson WP, Booth E, Weinfeld M and Le XC. (2001). Methods Mol. Biol., 162, 419-428.
190. Yang SC, Weinfeld M, Jenq SN, Kang ZC and Lee H. (2000). Chem. Res. Toxicol., 13, 1046-1050.
191. Yang K, Fang JL and Hemminki K. (1998). Mutat. Res., 422, 285-295.
192. Yi P, Sun X, Doerge DR and Fu PP. (1998). Chem. Res. Toxicol., 11, 1032-1041.
193. Yueh MF, Nguyen N, Famourzadeh M, Strassburg CP, Oda Y, Guengerich FP and Tukey RH. (2001). Carcinogenesis, 22, 943-950.
194. Zhang J, Ichiba M, Feng Y, Pan G, Hanaoka T, Yamano Y, Hara K, Takahashi K and Tomokuni K. (2000). Int. Arch. Occup. Environ. Health, 73, 127-135.
195. Zhou G, Hernandez NS, Randerath E and Randerath K. (2000). Mutat. Res., 447, 137-147.
196. Zienolddiny S, Ryberg D, Arab MO, Skaug V and Haugen A. (2001). Br. J. Cancer, 84, 226-231.